Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dementia/vômito

O link é salvo na área de transferência
Página 1 a partir de 171 resultados

Vomiting and painful abdomen in dementia.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se

A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE The two most common causes of dementia in the elderly are Alzheimer's disease (AD) and vascular dementia (VaD), which can coexist as mixed dementia. The object of this study was to assess the efficacy and safety of rivastigmine in patients with mixed dementia (AD with VaD). METHODS This

The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Inhibition of acetylcholinesterase improves symptoms of dementia in patients with Parkinson's disease (PD). Dementia in PD has a cumulative incidence of up to 80% and is mainly caused by a distinct cholinergic deficit. Objectives of this investigator initiated multicenter open label trial were to

Eighty-nine-year-old woman with abdominal pain and vomiting.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
UNASSIGNED An 89-year-old female patient presented to the ED with mild abdominal pain and a history of vomiting for 3 days. Because of dementia, further history was unclear. Vital signs were normal. Clinical examination revealed mild abdominal pain without defence or signs of peritonism. Bowel
The objective is to evaluate the efficacy of galantamine when a slow titration regimen is employed in Thai Alzheimer's disease (AD) patients with or without cerebrovascular disease and vascular dementia (VaD). A 6-month, multicentre, open-label, uncontrolled trial was undertaken in 75 AD patients.

[A case of ileus caused by a fecalith in an elderly patient with severe dementia].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
An 82-year-old woman with severe dementia, living in a nursing home, had severe chronic constipation, possibly due to the presence of multiple risk factors for constipation such as a past history of abdominal open surgery, diabetes, hypothyroidism, and bedridden status. She visited our department

Cholinesterase inhibitors for Parkinson's disease dementia.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease related symptoms particularly movement

Familial neuropathy with dementia, retinitis pigmentosa, and dysautonomia.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
We studied a 59-year-old woman with dementia, retinitis pigmentosa, sensorimotor neuropathy, and attacks of vomiting associated with blood pressure lability and loss of consciousness. Abnormalities included CT evidence of cerebral atrophy, low IQ, slow central and peripheral nerve conduction

[Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
RATIONALE IN ALZHEIMER'S DISEASE: Selective serotonine uptake inhibitors (SSRI) have demonstrated their effectiveness for symptomatic treatment of depression, as well as for behavioral and psychological disorders in dementia patients, particularly in Alzheimer's disease. UNASSIGNED SSRI are

Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
There is a global and continuing increase in the population of elderly people. This is particularly true among patients with cancer including those receiving chemotherapy. There are no guidelines that in particular address prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in the
To validate PDE4 inhibitors as novel therapeutic agents against vascular dementia (VaD), twenty-five derivatives were discovered from the natural inhibitor α-mangostin (IC50=1.31 μM). Hit-to-lead optimization identified a novel and selective PDE4 inhibitor 4e (IC50 = 17

[A 85-year-old woman with one year history of convulsion, dementia, and consciousness disturbance].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
We report a 85-year-old woman who died after one year history of convulsion, dementia, and consciousness disturbance. She was apparently well until January 6, 1995 when she was 85 year old; on that evening, she suddenly stated that some one was in her room and she became confused. A local MD gave

A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Rivastigmine patch is the first transdermal treatment to be approved for Alzheimer's disease (AD) and Parkinson's disease dementia in the USA and for AD in Europe. It provides smooth, continuous drug delivery, and has the potential to maintain rivastigmine concentrations within an optimal

Clinical experience of galantamine in dementia: a series of case reports.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To use case studies to add the benefit of personal experience with galantamine to published literature and to demonstrate the type of patients that may benefit from this treatment. METHODS We describe eleven patients, aged 57-90 years, fulfilling the consensus diagnostic criteria for

[Adverse events causing discontinuation of donepezil for Alzheimer's dementia].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND The objective was to investigate the frequency of adverse events (AE) as a cause for discontinuation of donepezil treatment for Alzheimer's dementia (DAT) in a geriatric memory unit. METHODS Five-year retrospective study of 123 donepezil-treated patients diagnosed with DAT or mixed
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge